Clinical Trials Logo

Clinical Trial Summary

The purpose of this observational study is to further evaluate the safety and performance of the EnligHTN™ Renal Denervation System in the treatment of patients with uncontrolled hypertension in clinical routine practice.

Clinical Trial Description

This is a post market, multi-center, open label, observational study. Approximately 500 subjects with uncontrolled hypertension will undergo renal artery ablation at approximately 40 investigational sites located in Germany and will be followed for 1 year post procedure.The expected duration of the investigation will be approximately 4 years. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT01996033
Study type Observational
Source Abbott Medical Devices
Status Completed
Start date October 2013
Completion date January 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03221114 - Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease N/A
Withdrawn NCT01939392 - Rapid Renal Sympathetic Denervation for Resistant Hypertension II Phase 2/Phase 3
Terminated NCT01966952 - Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension N/A
Completed NCT01699529 - Multi-electrode Radiofrequency Renal Denervation System Feasibility Study N/A
Completed NCT01418261 - SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension N/A
Active, not recruiting NCT01635998 - Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation N/A
Enrolling by invitation NCT02674464 - Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project) N/A
Terminated NCT01628198 - Impact of Renal SympAthetic DenerVation on Chronic HypErtension N/A
Not yet recruiting NCT03348878 - Descriptive Study of Drug Compliance in Uncontrolled Hypertensive Patients N/A
Completed NCT02006758 - Observational Study of the EnligHTN Renal Denervation System in Europe
Completed NCT02418091 - Integrated Population Program for Diabetic Kidney Disease N/A
Completed NCT00888433 - Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) N/A
Completed NCT01644604 - Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension N/A
Recruiting NCT03209154 - An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment N/A
Recruiting NCT03577990 - Technology Coaching Intervention for Black Women With Hypertension N/A
Recruiting NCT03281772 - Uncontrolled Hypertension Management (TEAM-HTN)
Completed NCT02334033 - Cystatin C and Uncontrolled Hypertension N/A
Recruiting NCT02164435 - Effects of Renal Sympathetic Denervation on the Cardiac and Renal Functions in Patients With Drug-resistant Hypertension Through MRI Evaluation N/A
Suspended NCT01679132 - BAROSTIM NEO HTN Pivotal Trial N/A
Completed NCT01628172 - Renal Sympathetic Denervation for the Management of Chronic Hypertension N/A